Stoneridge Reports Third Quarter 2026 Results
Continued Sales Momentum and Cost Discipline Highlight 3Q Progress NOVI, Mich., Nov. 4, 2026 — Stoneridge, Inc. (NYSE: SRI) today announced financial…
Archive
391 releases
Continued Sales Momentum and Cost Discipline Highlight 3Q Progress NOVI, Mich., Nov. 4, 2026 — Stoneridge, Inc. (NYSE: SRI) today announced financial…
Oral, highly selective and potent VAV1 molecular glue degrader designed to deliver a differentiated clinical profile across a broad range of…
Bruce Broussard to Succeed Chip Bergh as Chair of the Board
Achieves 30% Revenue Growth Year-Over-Year
Youlife Group Inc. ("Youlife" or the "Company") (NASDAQ: YOUL), a leading blue-collar lifetime service provider in China, today announced that it has…
Company raises full-year revenue and earnings outlook again and increases full-year cash flow expectations
Revenue growth of 27% driven by strong performance in molecular profiling services, including approximately 61,500 clinical cases, consisting of over…
SHOP Same Store Cash NOI increased 13.6% year-over-year —
Revenue grows 32% year over year to $718 million